Navigation Links
Over in Medical Technology

Isis Reports Strong Financial Results and Highlights for Second Quarter of 2009

... ended June 30, 2009, a significant improvement over the same period in 2008. Isis also reported a pro ... debt at a discount, which Isis is amortizing over the expected life of the debt as additional ... net income per share for the first half of 2009 over the same period in 2008 was primarily due to the ...

Study Shows Brain Fitness can Save Medicare Billions

... enrollees grows from 44 million to 61 million over the next ten years, this represents more than ... was based on a total of ten hours of training over one initial six-week period. Participants have ... brain fitness programs. The company works with over 50 scientists from prestigious universities to ...

Neurointerventionists Expand Research to Quality of Life in Aneurysm Patients Following Minimally Invasive Coiling Treatment

... refinements for coiling are underway all over the world. But while the efficacy of minimally invasive coiling has been proven many times over in the case of intracranial aneurysms (a bulge in ... aneurysms, carotid stenosis and spine fractures. over the past two decades, our physicians have made ...

Accent on Aesthetics Plastic Surgery Medical Center Selects Artefill to Meet Growing Patient Demand for a Longer Lasting Dermal Filler

... we have had great success with the product over the past few years as it's easy to administer and ... that are completely absorbed by the body over time and require repeat injections to maintain ... of Artefill has been extensively studied over the past eight years. Since Artefill was approved ...

Relievant Medsystems Announces Completion of $20 Million Financing

... partnering with more than 300 emerging companies over forty years. With offices in Menlo Park, Boston and Boulder, the firm manages over $3 billion in capital and invests in early stage ... 63 mergers and acquisitions, and brought over 50 companies public. www.canaan.com ...

New Data Supports Significant Economic and Clinical Value of MENOPUR(R) in IVF

... or HP-hMG) offered considerable cost-savings over recombinant follicle stimulating hormone ... budget, as it offers considerable cost savings over rFSH, not only in terms of costs per treatment ... in producing live-births over rFSH in women undergoing conventional IVF and, ...

AcelRx Announces Positive Phase 2 Results from a Study of ARX-01 Sufentanil NanoTabs in Treating Post-Operative Pain

... significant reductions in pain intensity over the 12-hour study period. This multicenter, ... measure of the difference in pain intensity over the 12-hour study compared to baseline). Both ... significant reductions in pain intensity over the study period (p<0.001 for each) based on ...

Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R)

... and sustained decrease in seizure frequency over the long-term(1). Results from the ... after a 2-week titration period, were assessed over a 12 week maintenance period, with continued follow-up over a one year open-label period. Efficacy ...

GeoVax Labs, Inc. Announces Results of 2009 Annual Shareholders Meeting

... at the meeting, highlighting significant progress over the past year. A few of the key advances ... to significantly decrease the prevalence of AIDS over time. About GeoVax Labs, Inc. GeoVax ... to use than GeoVax's products, and other factors over which GeoVax has no control. GeoVax assumes no ...

CoAxia, Inc. Announces $21.5M Series D Financing

... ischemic stroke. The company has now enrolled over 75% of its goal of approximately 500 patients, ... sectors. Since 1972, the firm has financed over 450 companies, many of which have gone public or have been acquired, and currently manages over euro 1 billion in assets. Sofinnova's experienced ...

Families of Spinal Muscular Atrophy Announces Latest Developments on Three SMA Drug Discovery Programs

... These three programs represent an investment of over $16 Million so far to build a SMA drug pipeline. ... data package. Families of SMA will be working over the next several months with toxicology and ... the 25th Anniversary SMA Conference. A record of over 900 families and researchers were present at the ...

HEALTHPOINT-Sponsored Venous Leg Ulcer Clinical Trial Enrolls First Subject for Second Phase II Study

... 2010. The first trial showed promising results over a four-fold range of cell concentrations ... and actual direct treatment costs reported to be over $9,000 per patient, the current annual cost of ... plus standard care, in healing venous leg ulcers over a 12-week treatment period. All trial patients ...

Neurocrine Biosciences Presents Elagolix Data

... a Phase I study in which elagolix was evaluated over six weeks (42 days) in 60 healthy premenopausal ... fashion to maintenance of low estradiol levels over the six week period without inducing severe hot ... 104 (used as an active control) administered over six months followed by six months of additional ...

VivoMetrics(R) Introduces Next Generation LifeShirt Prototype, a Smart Garment That Delivers Real-time Vital Signs Remotely to Healthcare Providers

... The new LifeShirt has significant advantages over currently available monitoring technologies, ... resulting from RPM will reach $200 billion over the next 25 years in the United States alone(1). ... It's exciting for us to be able to draw upon over 10 years of experience acquiring quality data in ...

Study Shows GSK's Novel Diabetes Treatment SYNCRIA(R) (albiglutide) Improves Glucose Control and Reduces Weight

... managing type 2 diabetes, a disease that affects over 250 million people worldwide. In the ... of how well blood sugar is being controlled over time - with albiglutide 30 mg weekly, 50 mg ... "Despite a range of available diabetes therapies, over half of patients with type 2 diabetes are unable ...

Arena Pharmaceuticals Announces Lorcaserin Data Demonstrating Highly Significant Categorical and Absolute Weight Loss and Improvements in Secondary Endpoints Associated with Cardiovascular Risk

... 32.1% of patients on placebo (p<0.0001), and over one-third (36.2%) of lorcaserin patients lost at ... data demonstrate that treatment with lorcaserin over one year was associated with highly significant ... of valvulopathy for lorcaserin patients crossing over to placebo were 3.6% and 1.9%, respectively. ...

AFRESA(R) Phase 3 Pulmonary Function Safety Data in Patients with Diabetes Presented at ADA

... prospective, multicenter, phase 3 study conducted over a two-year period showed no difference in mean ... were based on pulmonary function tests (PFTs) over a 2-year period in subjects with type 1 and 2 ... group. Based on the predefined endpoint, over 2 years, there was no difference in mean change ...

Prometheus Announces New Findings Regarding Patients at Risk for Celiac Disease at DDW

... literature suggesting biomarker stability over similar time periods. Further studies are ... the impact of therapy on biomarker stability over longer periods of time. The clinical utility ... patients is expected to increase significantly over the next several years, driven by broad-based ...

PROTECT-1 Phase II/III Induction-Stage Results for ChemoCentryx's Traficet-EN(TM) Presented in Oral Session at DDW 2009 Conference

... Activity Index (CDAI) score of at least 70 points over the course of 12 weeks; the more stringent ... maintaining response/remission in Crohn's disease over a combined total of 12 months. The Induction ... oral dosing. Traficet-EN may offer advantages over existing therapeutic approaches for Crohn's ...

Neurobiological Technologies' Partner, Celtic Pharma, Announces Results of XERECEPT(R) Phase 3 Clinical Program

... both in terms of lowering dexamethasone use over the longer-term and the impact seen in metastatic ... dexamethasone dosing much better than anticipated over this time frame. However, at weeks two, ... (p=0.001) improvement compared to placebo over the twelve weeks of study duration in reducing ...

PAREXEL Reaches Milestone in Management of Oncology Trials Over Last Five Years Involving 175,000 Patients Worldwide

... in managing oncology-based clinical trials over the last five years, which have involved over 175,000 patients in hundreds of programs across ... throughout 52 countries around the world, and has over 9,400 employees. For more information about ...

Blanchette Rockefeller Neurosciences Institute and Inverness Medical Innovations to Develop Commercial Test to Detect Early Alzheimer's Disease

... the development efforts to be conducted by BRNI over an initial three year period. Inverness has also ... diseases such as Alzheimer's." Affecting over 5 million Americans, Alzheimer's disease (AD) has ... was $21 billion. Dementia currently afflicts over 29 million people worldwide, and the annual ...

Stand Up To Cancer Awards $73.6 Million for Novel, Groundbreaking Cancer Research

... 4 co-leaders and 27 principal researchers from over 20 leading institutions, with more than 300 ... cancer. These grants will provide up to $750,000 over a three-year term, and will be awarded to ... If the Dream Teams produce tangible results over these next three years, the Stand Up To Cancer ...

New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal

... HCl IR 10-mg, or placebo every four to six hours over a 72-hour period following surgery. The primary ... was the sum of pain intensity difference (SPID) over the first 48 hours of treatment. The secondary endpoints included SPID over the first 12, 24, and 72 hours of treatment, ...

Swine Flu (H1N1) Infectivity to Increase Markedly and Lethality to Remain Low According to Latest Replikin* Peptide Genomic Data

... May 23 /PRNewswire/ -- Amid all the speculation over what course the Swine Flu epidemic will take, ... showed an increase of 46% in the Replikin Count* over the past five months. This points to a marked ... and pandemics of the common influenza strains over the past century. About Replikins Ltd . ...

Lilly Advances Second Alzheimer's Disease Treatment Candidate Into Late-Stage Testing by Launching Two Global Trials

... to enroll a total of 2,000 patients age 55 and over from 16 countries. In 2008, Lilly began ... 4,600 patients with Alzheimer's disease in over 30 countries around the world. EXPEDITION ... Estimates show that 6-8 percent of people over age 65 are affected by Alzheimer's disease(iii), ...

Dainippon Sumitomo Pharma Announces Lurasidone Phase III Data in Patients With Schizophrenia

... 80 mg and 120 mg once daily compared to placebo, over six weeks in patients with acute schizophrenia. ... was change from baseline in the PANSS total score over the six-week study duration for each lurasidone ... endpoint was the change from baseline in CGI-S over the six-week study period. Efficacy data were ...

Chuck Panozzo, Founder of Rock Band Styx, Joins GeoVax Labs, Inc. as an Advocate for Its HIV/AIDS Vaccine

... lost many relatives and friends to HIV/AIDS over the years, I found Dr. Robinson's quest for a ... people from all classes in America and all over the world. Chuck is a true advocate of what we ... to use than GeoVax's products, and other factors over which GeoVax has no control. GeoVax assumes no ...

Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF Presented at American Thoracic Society (ATS)

... change from baseline, assessing treatment effect over the full duration of the study showed that ... that pirfenidone has on the progression of IPF over at least one year." About CAPACITY and ... cough and is a progressive disease, meaning that over time, lung scarring and symptoms increase in ...

Unique Cardiovascular Treatment Readied for Global Market: Proprietary Paccocath(R) Technology is the Only Drug Eluting Balloon with Clinical Data

... Technology closer to market as an option for the over 14 million patients in the United States and ... procedure keeps the vessels open wider over time compared to standard angioplasty and ... services. MEDRAD's total 2008 revenues were over $600 million. The company's world headquarters is ...

New MADIT II Clinical Data Analysis Shows Long-Term Survival Benefit for Implantable Defibrillator Therapy

... analysis shows a sustainable mortality benefit over time, including: At eight ... ICD. This represents a significant improvement over the two-year MADIT II data, which showed one life ... life-saving benefits of these devices continue over time," said Arthur J. Moss, M.D., Professor of ...

Circassia Begins Phase II Clinical Trial With Ragweed Allergy Therapy

... which require careful dose escalation over many months and several years of maintenance ... standardized doses of ToleroMune treatment over a number of weeks. During the trial investigators ... are very common in the US, where they affect over a quarter of the population, and are a growing ...

CMC ICOS Biologics and Implicit Bioscience Ltd Announce IC14 Antibody Manufacturing Agreement and Patent License

... (ALI). IC14 has a demonstrated safety profile in over 150 patient exposures, and initial data from a ... and appreciate their particular insights gained over their years of experience in the earlier ... cases per annum in the US and is responsible for over 75,000 deaths - more than breast cancer and HIV ...

Methadone Frequently Causes Menopausal Symptoms in Young Women

... daily. Florida Detox has successfully detoxed over 100 methadone patients who were using over 1000 milligrams of methadone daily Florida ... Cocaine dependency. Florida Detox has treated over 5,000 patients for chemical dependency. ...

Results From Phase 3 EQUATE Trial of VIVUS' Qnexa Highlighted at European Congress on Obesity

... that achieved with placebo among 756 patients over 28 weeks. Patients taking full-dose and mid-dose ... "The weight loss seen in patients taking Qnexa, over just 28 weeks, is encouraging for those of us in ... weight loss of five percent of weight, maintained over time, can bring significant health benefits by ...

BioInformatics, LLC New Report - Capitalizing on New Opportunities for Stem Cell Products, Now Available

... products is expected to increase substantially over the next several years to $688.9 M in 2009 and ... types are expected to be of increasing interest over the next couple of years. By 2011, osteogenic ... excitement, especially in the academic community, over the recent Executive Order signed by President ...

Lions Eye Institute for Transplant & Research, Inc. Launches Multi-Million Dollar, State-of-the-Art Research Institute that Will Advance the Study of Blinding Eye Diseases

... For more than 30 years, LEITR has provided over 30,000 corneas for transplant and 50,000 eyes for ... the highest quality human tissue available. over the years, LEITR recognized that time between ... upwards of 3 million Americans, contributes to over 120,000 new cases of blindness each year and is ...

ARVO, AOS: Large Study of Lacrisert(R) Dry Eye Insert;

... providing a rich resource of data to mine over time. Association for Research in Vision ... the study significantly improved by more than 25% over the four weeks of the study; this was over and above any improvement patients may have ...

Perceptive Informatics Survey Results Reveal Top Barriers to Implementing Adaptive Trial Designs

... statistical applications, was attended by over 500 professionals from the biopharmaceutical ... which has supported the implementation of over 100 adaptive trials, provides eClinical ... throughout 52 countries around the world, and has over 9,400 employees. For more information about ...

Two-Year Phase III Data Presented at AAN 61st Annual Meeting Show Positive Outcome of Cladribine Tablets in Patients With Multiple Sclerosis

... treatment groups than in the placebo group. over the two-year period of the study, 80% of the ... (another secondary endpoint) relative to placebo over the two-year period of the study (low-dose ... shown and were consistent with clinical outcomes. over the two year period of the study, both dose ...
Other Contents
(Date:7/11/2014)... from Salk Institute for Biological Studies, BGI, and ... safety and reliability of the existing targeted gene ... TALEN-HDAdV, which could significantly increased gene-correction efficiency in ... published online in Cell Stell Cell ... gene therapy. , The combination of stem cells ...
(Date:7/11/2014)... July 11, 2014 Researchers have pioneered ... images. The new technology, called Virtual Finger, allows ... structures like neurons and synapses using the flat ... technology makes 3D imaging studies orders of magnitude ... an unprecedented level across many areas of experimental ...
(Date:7/11/2014)... normal circumstances, astrocytes participate in normal physiological ... exhibit therapeutic and repairing effects on brain ... found that nerve cells differentiated from adipose-derived ... viability, which produces influences on subsequent studies ... Hospital, Hebei United University, China demonstrated that ...
Breaking Biology News(10 mins):A new genome editing method brings the possibility of gene therapies closer to reality 2Virtual finger enables scientists to navigate and analyze complex 3D images 2
(Date:7/13/2014)... MillionaireCasket.com is a professional supplier of funeral products. According to ... well in the global market. Recently, the company has announced ... a special offer for all the newly released items. ... caskets are made with superb materials. As is commonly noted, ... respect to the departed saint. MillionaireCasket.com is always here to ...
(Date:7/13/2014)... 13, 2014 Intraocular Lens (IOL) Market: ... 2013 - 2019 , Intraocular lens (IOL) is inserted ... or cataracts. The lenses are inserted inside the eye, ... intraocular lens replaces the focusing power of natural lens. ... lens to deliver the light focusing function which was ...
(Date:7/13/2014)... Victorian Hotel has recently announced that ... of bikes for its "Cycle the City" program, which ... tour the area using a rental bicycle, available for ... to call Vancouver home, as it is a city ... picturesque journeys through the countryside. Vancouver hotel rooms often ...
(Date:7/13/2014)... additives are chemicals, which are added to various fuels ... on, in order to enhance their performance. Fuel additives ... by fuels and improving the combustion properties of fuels. ... scale in the long run, but, in the short ... products. , The various fuel additive types include deposit ...
(Date:7/13/2014)... The Pearland, Texas location of The Little Gym, a ... to 12 years of age that offers everything from gymnastics, ... Summer Camps, is now under new ownership. , Kevin Berry ... spending over six years at The Little Gym of Bellaire ... Berry has over ten years of experience working with children, ...
Breaking Medicine News(10 mins):Health News:Brand New Cherry Caskets Unveiled By China Casket Supplier MillionaireCasket.com 2Health News:Intraocular Lens (IOL) Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 2Health News:Intraocular Lens (IOL) Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 3Health News:Intraocular Lens (IOL) Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 4Health News:Victorian Hotel Creates Excitement by Adding "Cycle the City" Bike Rentals for Its Vancouver Hotel Rooms 2Health News:North America Fuel Additives Market is Expected to Reach $8,100 Million by 2017 - New Report by MicroMarket Monitor 2Health News:North America Fuel Additives Market is Expected to Reach $8,100 Million by 2017 - New Report by MicroMarket Monitor 3Health News:North America Fuel Additives Market is Expected to Reach $8,100 Million by 2017 - New Report by MicroMarket Monitor 4Health News:The Little Gym of Pearland, TX Now Under New Ownership and Management 2
Other TagsOther Tags